R E Carroll

Summary

Affiliation: University of Illinois at Chicago
Country: USA

Publications

  1. doi Management and Complications of Short Bowel Syndrome: an Updated Review
    Robert E Carroll
    Intestinal Rehabilitation and Transplant Center, Departments of Medicine and Surgery, University of Illinois at Chicago and Chicago Veterans Administration Medical Center West Side Division, 840 South Wood Street m c 787, Chicago, IL, 60612, USA
    Curr Gastroenterol Rep 18:40. 2016
  2. ncbi Colon preparation for magnification endoscopy: a rapid novel approach
    R E Carroll
    Dept of Medicine, University of Illinois at Chicago Chicago Veterans Administration Medical Center West Side Division, 840 South Wood Street m c 787, Chicago, IL 60612, USA
    Endoscopy 36:609-11. 2004
  3. pmc Reduced susceptibility to azoxymethane-induced aberrant crypt foci formation and colon cancer in growth hormone deficient rats
    Robert E Carroll
    Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA
    Growth Horm IGF Res 19:447-56. 2009
  4. pmc Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia
    Robert E Carroll
    Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA
    Cancer Prev Res (Phila) 4:354-64. 2011
  5. ncbi The case for gastrin-releasing peptide acting as a morphogen when it and its receptor are aberrantly expressed in cancer
    J A Jensen
    Department of Medicine, University of Illinois at Chicago and Chicago Veterans Administration Medical Center (West Side Division, Chicago, Illinois 60612, USA
    Peptides 22:689-99. 2001
  6. doi Extent of prevalence and size of flat neoplasms in a heterogeneous population undergoing routine colorectal cancer screening
    J Kim
    Cancer Center and Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA
    Colorectal Dis 12:471-6. 2010
  7. ncbi Gastrin-releasing peptide is a mitogen and a morphogen in murine colon cancer
    R E Carroll
    Department of Medicine, University of Illinois at Chicago, and Chicago Veterans Administration Medical Center, 60612, USA
    Cell Growth Differ 11:385-93. 2000

Collaborators

Detail Information

Publications7

  1. doi Management and Complications of Short Bowel Syndrome: an Updated Review
    Robert E Carroll
    Intestinal Rehabilitation and Transplant Center, Departments of Medicine and Surgery, University of Illinois at Chicago and Chicago Veterans Administration Medical Center West Side Division, 840 South Wood Street m c 787, Chicago, IL, 60612, USA
    Curr Gastroenterol Rep 18:40. 2016
    ..This review will focus on developments over the last 10 years with the goal of updating the reader to new advances in our understanding of the care and feeding of the SBS patient. ..
  2. ncbi Colon preparation for magnification endoscopy: a rapid novel approach
    R E Carroll
    Dept of Medicine, University of Illinois at Chicago Chicago Veterans Administration Medical Center West Side Division, 840 South Wood Street m c 787, Chicago, IL 60612, USA
    Endoscopy 36:609-11. 2004
    ..Patients and Methods : Seven patients received dilute methylene blue (0.05 %) by enema prior to the endoscopic evaluation. The extent, quality, and ease of dye delivery were compared with the standard methods...
  3. pmc Reduced susceptibility to azoxymethane-induced aberrant crypt foci formation and colon cancer in growth hormone deficient rats
    Robert E Carroll
    Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA
    Growth Horm IGF Res 19:447-56. 2009
    ....
  4. pmc Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia
    Robert E Carroll
    Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA
    Cancer Prev Res (Phila) 4:354-64. 2011
    ..009). Curcumin was well tolerated at both 2 g and 4 g. Our data suggest that curcumin can decrease ACF number, and this is potentially mediated by curcumin conjugates delivered systemically...
  5. ncbi The case for gastrin-releasing peptide acting as a morphogen when it and its receptor are aberrantly expressed in cancer
    J A Jensen
    Department of Medicine, University of Illinois at Chicago and Chicago Veterans Administration Medical Center (West Side Division, Chicago, Illinois 60612, USA
    Peptides 22:689-99. 2001
    ..Thus aberrant GRP/GRP-R expression in cancer recapitulates, albeit in a dysfunctional manner, their normal role in development...
  6. doi Extent of prevalence and size of flat neoplasms in a heterogeneous population undergoing routine colorectal cancer screening
    J Kim
    Cancer Center and Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA
    Colorectal Dis 12:471-6. 2010
    ..The importance of identifying flat colorectal neoplasms is increasingly appreciated, although the extent of prevalence of these lesions in a general population is not known...
  7. ncbi Gastrin-releasing peptide is a mitogen and a morphogen in murine colon cancer
    R E Carroll
    Department of Medicine, University of Illinois at Chicago, and Chicago Veterans Administration Medical Center, 60612, USA
    Cell Growth Differ 11:385-93. 2000
    ..Rather, the mitogenic properties of GRP are subordinate to it acting as a morphogen, where it and its receptor are critically involved in regulating colon cancer histological progression by promoting a well-differentiated phenotype...